Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PharmaBiome AG logo — Pioneering the development of microbiome-based therapies usi...

PharmaBiome AG

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.

Founded 2015 Switzerland Zurich, Switzerland 11 employees Convertible Note Total: $1.98M Biotechnology, Health Care

General Information

Company Name PharmaBiome AG
Founded Year 2015
Location Switzerland Zurich, Switzerland
Founders / Decision Makers
Team member
Employees 11
Industries Biotechnology, Health Care
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with PharmaBiome AG. To contact PharmaBiome AG, visit pharmabiome.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PharmaBiome AG compare?

A PDF of PharmaBiome AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PharmaBiome AG soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PharmaBiome AG

PharmaBiome AG is a Swiss-based startup that is pioneering the development of microbiome-based therapies using proprietary tools for their design and production. Founded in 2015 as a spin-off from ETH Zurich, the company has created a first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Situated at the intersection of microbiology, biotechnology, and data science, PharmaBiome is focused on developing the biotechnology necessary to produce solutions compliant with the safety, efficacy, and trial requirements of human medicine. The company has invested significant time in developing a biology-based analysis tool that allows for the identification and selection of the metabolic functions essential to restore the gut microbiome to a balanced state. PharmaBiome has been recognized with several startup awards, including Venture Kick, the ETH Spark Award, and the BaseLaunch Accelerator. Its most recent investment was a Fr.1.75M Convertible Note investment on 08 July 2020. PharmaBiome's innovative approach holds promise in creating personalized treatments for patients with chronic inflammatory diseases, immune conditions, and special nutritional needs. The flexibility and speed of their production process provide a unique advantage in creating effective treatment options. With its focus on addressing disturbances of the gut microbiome, PharmaBiome AG stands at the forefront of advancing microbiome-based therapies.

Business keywords: Microbiome-based Therapies, Biotherapeutics, Microbiology, Patent-Protected Technology, Start-up Awards, Intestinal Microbes, Gut Microbiome, Chronic Inflammatory Diseases, Immune Conditions, Nutritional Therapy, Biological Analysis, Clinical Translation, Function-Based Therapies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Fr.1.75M -
08 Jul 2020
Seed Round Undisclosed 1
BaseLaunch
BaseLaunch
21 Jan 2020
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Apr 2018
Pre Seed Round Fr.130.00K 1
Venture Kick
Venture Kick
14 Jun 2016
Grant Fr.10.00K 1
Venture Kick
Venture Kick
28 Apr 2016
Grant Fr.20.00K 1
Venture Kick
Venture Kick
16 Sep 2015

PharmaBiome AG Alternatives & Competitors

View All Alternatives
PharmaBiome AG vs
Ritter Pharmaceuticals
Ritter Pharmaceuticals

Pioneering the future of gut health with novel microbiome modulators for impactful patient outcomes.

Post-IPO Equity
Biotechnology, Health Care
PharmaBiome AG vs
Exeliom Biosciences
Exeliom Biosciences France

Crossing the next frontier, to give you a fair chance to fight

Seed
8 employees
Biopharma, Biotechnology
PharmaBiome AG vs
Avontec Automation Pvt Ltd
Avontec Automation Pvt Ltd India

Automation through Innovation

Grant
17 employees
Biotechnology, Health Care
View all alternatives

FAQ About PharmaBiome AG

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.
PharmaBiome AG was founded in 2015.
PharmaBiome AG is headquartered in Zurich, Switzerland.
PharmaBiome AG operates in Biotechnology and Health Care. Its work centres on Microbiome-based Therapies, Biotherapeutics, Microbiology and Patent-Protected Technology.
PharmaBiome AG has approximately 11 employees.
PharmaBiome AG has completed 6 funding rounds, raising a total of $1.98M. The latest funding stage is Convertible Note.
Top alternatives and competitors to PharmaBiome AG include Ritter Pharmaceuticals, Exeliom Biosciences, Avontec Automation Pvt Ltd, GMT Science, Nextera AS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmaBiome AG and Ritter Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PharmaBiome AG, https://bouncewatch.com/company/pharmabiome-ag, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout